ViiV Healthcare Presents Phase III Data at AIDS 2018 from Landmark GEMINI Studies Showing Two-Drug Regimen of Dolutegravir and Lamivudine Has Similar Efficacy to a Three-Drug Regimen in Treatment Naï
Go back to ViiV Healthcare Presents Phase III Data at AIDS 2018 from Landmark GEMINI Studies Showing Two-Drug Regimen of Dolutegravir and Lamivudine Has Similar Efficacy to a Three-Drug Regimen in Treatment Naï| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.07 +1.33 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.74 | 52 Week High | $45.58 | |||
| Open | $51.63 | 52 Week Low | $37.82 | |||
| Day High | $52.12 | P/E | N/A | |||
| Day Low | $51.51 | EPS | $0.00 | |||
| Volume | 3,008,311 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.07 +1.33 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.74 | 52 Week High | $45.58 | |||
| Open | $51.63 | 52 Week Low | $37.82 | |||
| Day High | $52.12 | P/E | N/A | |||
| Day Low | $51.51 | EPS | $0.00 | |||
| Volume | 3,008,311 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.72 -0.36 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.08 | 52 Week High | $37.39 | |||
| Open | $24.99 | 52 Week Low | $28.25 | |||
| Day High | $25.24 | P/E | 14.98 | |||
| Day Low | $24.69 | EPS | $1.65 | |||
| Volume | 81,994,445 | |||||
